How much funding has Clovis Oncology raised?

Clovis Oncology has raised $145.0M in total funding, most recently a Series A round.

Who are Clovis Oncology's investors?

Clovis Oncology's investors include Domain Associates, NEA, Jerel Davis, Aberdare Ventures, Frazier Healthcare, Abingworth Bioventures.

When was Clovis Oncology founded?

Clovis Oncology was founded in 2009.

Where is Clovis Oncology headquartered?

Clovis Oncology is headquartered in Boulder, Colorado, United States.

What industry is Clovis Oncology in?

Clovis Oncology operates in Biotech, Oncology.

How many employees does Clovis Oncology have?

Clovis Oncology has 201-500 employees.

Clovis Oncology

IPO

Public · Boulder, United States · Founded 2009 · $145.0M raised

Biotech

Oncology

Headquarters: Boulder, Colorado
Employees: 201–500
Founded: 2009
Business Model: B2B
Website: clovisoncology.com

Total Funding: $145.0M
Last Round: $145.0M Series AMay 2009
Rounds: 1
Type: Public

About

Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe, and other international markets. The company's approach to precision medicine aims to deliver the right drug to the right patient at the right time, targeting specific subsets of cancer. Clovis develops diagnostic tools in collaboration with partners to direct compounds to patients most likely to benefit.

Summary

Clovis Oncology is a Biotech company based in Boulder, United States, founded in 2009. It has raised $145.0M in total across 1 round, most recently a $145.0M Series A round in May 2009. Investors include Domain Associates, NEA and Jerel Davis.

LinkedIn X (Twitter)